1. Home
  2. CRS vs BNTX Comparison

CRS vs BNTX Comparison

Compare CRS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carpenter Technology Corporation

CRS

Carpenter Technology Corporation

HOLD

Current Price

$428.44

Market Cap

21.3B

Sector

Industrials

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$104.95

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRS
BNTX
Founded
1910
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3B
24.2B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CRS
BNTX
Price
$428.44
$104.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$410.38
$133.46
AVG Volume (30 Days)
689.3K
805.3K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.19%
N/A
EPS Growth
100.54
N/A
EPS
4.52
N/A
Revenue
$2,157,700,000.00
N/A
Revenue This Year
$9.21
N/A
Revenue Next Year
$10.50
$3.37
P/E Ratio
$93.52
N/A
Revenue Growth
20.03
N/A
52 Week Low
$188.12
$79.81
52 Week High
$459.18
$124.00

Technical Indicators

Market Signals
Indicator
CRS
BNTX
Relative Strength Index (RSI) 55.14 61.06
Support Level $297.11 $99.08
Resistance Level N/A $113.02
Average True Range (ATR) 16.85 3.51
MACD -1.11 1.58
Stochastic Oscillator 58.33 68.56

Price Performance

Historical Comparison
CRS
BNTX

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: